Back to Search
Start Over
Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era.
- Source :
-
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2014 Feb; Vol. 14 (1), pp. e7-e11. Date of Electronic Publication: 2013 Oct 26. - Publication Year :
- 2014
- Subjects :
- B-Lymphocytes pathology
Female
Hodgkin Disease pathology
Humans
Lenalidomide
Middle Aged
Multiple Myeloma pathology
Thalidomide adverse effects
Thalidomide therapeutic use
B-Lymphocytes drug effects
Hodgkin Disease etiology
Immunologic Factors adverse effects
Immunologic Factors therapeutic use
Multiple Myeloma drug therapy
Thalidomide analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 2152-2669
- Volume :
- 14
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Clinical lymphoma, myeloma & leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 24169269
- Full Text :
- https://doi.org/10.1016/j.clml.2013.07.101